https://kenyamazaki.com/2026/09/03/26/Ken リクルターブログja2026-09-02T20:00:00+00:00トランプ「最恵国薬価」政策、対象26社のリストAbbVie, pfizer, GSK, amgen, TEVA, UCB, novartis, Takeda, Merck, GLP-1, sanofi, novo nordisk, MAHA, Trump, Eli Lilly, Regeneron, Robert F. Kennedy Jr., Johnson & Johnson, Biotech, BeOne Medicines, Pharmaceutical Industry, RFK Jr., drug pricing, tariffs, Medicaid, healthcare policy, MFN, AstraZeneca, Boehringer Ingelheim, PhRMA, US politics, midterm elections, pharma stocks, TrumpRx, EMD Serono, Midsized Biotech Alliance of America, Kyowa Kirin, Japan pharma, Bristol Myers Squibb, midsize biotech, drug price reform, Gilead Sciences, Sun Pharma, CSL, Genentech, Alcon, healthcare affordability, Most Favored Nation, Astellas, BridgeBiohttps://kenyamazaki.com/wp-content/uploads/2026/09/pexels-photo-8175100.jpeg?w=150